Jyostna Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 2.80%
- Ebitda -1.30%
- Net Worth -17.71%
- Total Assets -0.55%
About Jyostna Laboratories
Jyostna Laboratories Private Limited (JLPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 September 2008 and has a history of 16 years and four months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkateshwar Kumar and Thaduri Srivani serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900TG2008PTC061233
- Company No.
061233
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Jyostna Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateshwar Kumar  | Managing Director | 27-Dec-2008 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thaduri Srivani | Director | 28-May-2009 | Current |
Financial Performance of Jyostna Laboratories.
Jyostna Laboratories Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 2.8% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jyostna Laboratories?
In 2017, Jyostna Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stereokem Private LimitedVenkateshwar Kumar and Thaduri Srivani are mutual person
Stereokem Pharmaceuticals Private LimitedVenkateshwar Kumar and Thaduri Srivani are mutual person
Genotech Pharmaceuticals Private LimitedThaduri Srivani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jyostna Laboratories?
Unlock and access historical data on people associated with Jyostna Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jyostna Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jyostna Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
